Companies /Healthcare

Bristol-Myers Squibb Company

NYSE: BMY Drug Manufacturers - General
$59.12
▼ $0.46 (−0.77%) today
Markets closed · 4:20am ET

BMY Coverage Page 41

12:33pm ET
Health and Healthcare

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Bristol-Myers (BMY) showed the world its equivalent of the old Soviet "Five Year Plan" today. All of the talk up front was about becoming "a next-generation BioPharma company that pairs the scale…

BMY
Douglas A. McIntyre
5:28pm ET
Health and Healthcare

A Little Trouble For Bristol-Myers (BMY) Plavix

Plavix from Bristol-Myers (BMY) is the medical drug-thinner of choice. According to CNN Money, sales of the drug "totaled $3.4 billion in sales during the first nine months"  Now Eli Lilly (LLY)…

Douglas A. McIntyre
7:51am ET
Health and Healthcare

Medarex Hit With Sell Rating (MEDX, BMY)

Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL" rating.  This is a fairly thin volume stock in pre-market trading, but…

Douglas A. McIntyre
9:19am ET
Investing

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s, one of the most damaging and fastest growing diseases. Pfizer’s (PFE) Lipitor…

Douglas A. McIntyre
6:24am ET
Investing

Earlybird Analyst Calls (June 25, 2007)

Stock Tickers: ABI, BBSI, BMY, CAP, CLUB, CVX, FCBP, GM, IPG, OMC, MIG, PER, PIR, SKH, SMSI, TRLG ABI raised to Outperform at Baird.BBSI raised to Strong Buy at JMP Securities.BMY raised…

Douglas A. McIntyre
7:11am ET
Investing

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering integration.(BMY) Bristol-Myers: FDA Grants…

Douglas A. McIntyre
4:36pm ET
Health and Healthcare

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April.  Below is…

Douglas A. McIntyre